0001654954-22-001635.txt : 20220214
0001654954-22-001635.hdr.sgml : 20220214
20220214161336
ACCESSION NUMBER: 0001654954-22-001635
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHROTRIYA RAJESH C MD
CENTRAL INDEX KEY: 0001193918
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40023
FILM NUMBER: 22632023
MAIL ADDRESS:
STREET 1: 157 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: SUITE 100
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: SUITE 100
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2021-02-16
0000109657
GT Biopharma, Inc.
GTBP
0001193918
SHROTRIYA RAJESH C MD
C/O GT BIOPHARMA, INC.
8000 MARINA BLVD., STE. 100
BRISBANE
CA
94005
true
Option to purchase Common Stock
6.33
2021-02-16
4
A
false
50000
0
A
2031-02-15
Common Stock
50000
50000
D
1/3rd of the shares vest on February 16, 2021, 2022 and 2023.
/s/ Rajesh Shrotriya
2022-02-14